Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed the day trading at $0.19 down -54.47% from the previous closing price of $0.43. In other words, the price has decreased by -$54.47 from its previous closing price. On the day, 319.34 million shares were traded. TNXP stock price reached its highest trading level at $0.255 during the session, while it also had its lowest trading level at $0.18.
Ratios:
For a better understanding of TNXP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.78 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 36425640 and an Enterprise Value of 8208987. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.23 while its Price-to-Book (P/B) ratio in mrq is 0.41. Its current Enterprise Value per Revenue stands at 0.659 whereas that against EBITDA is -0.09.
Stock Price History:
The Beta on a monthly basis for TNXP is 2.08, which has changed by -0.9592803 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $12.48, while it has fallen to a 52-week low of $0.12. The 50-Day Moving Average of the stock is -33.13%, while the 200-Day Moving Average is calculated to be -85.22%.
Shares Statistics:
Over the past 3-months, TNXP traded about 127.92M shares per day on average, while over the past 10 days, TNXP traded about 143327980 shares per day. A total of 186.89M shares are outstanding, with a floating share count of 186.89M. Insiders hold about 0.00% of the company’s shares, while institutions hold 2.37% stake in the company. Shares short for TNXP as of 1730332800 were 7670373 with a Short Ratio of 0.12, compared to 1727654400 on 8291753. Therefore, it implies a Short% of Shares Outstanding of 7670373 and a Short% of Float of 5.48.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Tonix Pharmaceuticals Holding Corp (TNXP) in the stock market.The consensus estimate for the next quarter is -$6.4, with high estimates of -$6.4 and low estimates of -$6.4.
Analysts are recommending an EPS of between -$35.52 and -$35.52 for the fiscal current year, implying an average EPS of -$35.52. EPS for the following year is -$27.84, with 1.0 analysts recommending between -$27.84 and -$27.84.
Revenue Estimates
2 analysts predict $3.2M in revenue for the current quarter. It ranges from a high estimate of $4.1M to a low estimate of $2.3M. As of the current estimate, Tonix Pharmaceuticals Holding Corp’s year-ago sales were $3.78MFor the next quarter, 2 analysts are estimating revenue of $4.2M. There is a high estimate of $4.2M for the next quarter, whereas the lowest estimate is $4.2M.
A total of 2 analysts have provided revenue estimates for TNXP’s current fiscal year. The highest revenue estimate was $15.8M, while the lowest revenue estimate was $9.8M, resulting in an average revenue estimate of $12.8M. In the same quarter a year ago, actual revenue was $7.77MBased on 2 analysts’ estimates, the company’s revenue will be $13.35M in the next fiscal year. The high estimate is $17.2M and the low estimate is $9.5M.